215 related articles for article (PubMed ID: 12190110)
1. Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity.
Semiz S; McNeill JH
Mol Cell Biochem; 2002 Jul; 236(1-2):123-31. PubMed ID: 12190110
[TBL] [Abstract][Full Text] [Related]
2. Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats.
Semiz S; Orvig C; McNeill JH
Mol Cell Biochem; 2002 Feb; 231(1-2):23-35. PubMed ID: 11952162
[TBL] [Abstract][Full Text] [Related]
3. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
4. Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats.
Yuen VG; Pederson RA; Dai S; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1996 Sep; 74(9):1001-9. PubMed ID: 8960391
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats.
Marzban L; Bhanot S; McNeill JH
Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716
[TBL] [Abstract][Full Text] [Related]
6. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
Henriksen EJ; Kinnick TR; Teachey MK; O'Keefe MP; Ring D; Johnson KW; Harrison SD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E892-900. PubMed ID: 12517738
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda /zeta but not on glycogen synthase kinase-3.
Kim YB; Shulman GI; Kahn BB
J Biol Chem; 2002 Sep; 277(36):32915-22. PubMed ID: 12095990
[TBL] [Abstract][Full Text] [Related]
8. Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo.
Mohammad A; Wang J; McNeill JH
Mol Cell Biochem; 2002 Jan; 229(1-2):125-8. PubMed ID: 11936837
[TBL] [Abstract][Full Text] [Related]
9. Alterations of nPKC distribution, but normal Akt/PKB activation in denervated rat soleus muscle.
Lin Y; Brady MJ; Wolanske K; Holbert R; Ruderman NB; Yaney GC
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E318-25. PubMed ID: 12110537
[TBL] [Abstract][Full Text] [Related]
10. The effect of acute (60 minute) insulin stimulation upon human skeletal muscle glycogen synthase and protein phosphatase-1 in non-insulin-dependent diabetic patients and control subjects.
Barriocanal LA; Borthwick AC; Stewart M; Wells A; Hurel SJ; Yeaman SJ; Taylor R
Diabet Med; 1995 Dec; 12(12):1110-5. PubMed ID: 8750222
[TBL] [Abstract][Full Text] [Related]
11. Effect of vanadium on insulin sensitivity and appetite.
Wang J; Yuen VG; McNeill JH
Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143
[TBL] [Abstract][Full Text] [Related]
12. Activation of glycogen synthase in myocardium induced by intermittent hypoxia is much lower in fasted than in fed rats.
Wu Y; Wang H; Brautigan DL; Liu Z
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E469-75. PubMed ID: 17003235
[TBL] [Abstract][Full Text] [Related]
13. The skeletal muscle-specific glycogen-targeted protein phosphatase 1 plays a major role in the regulation of glycogen metabolism by adrenaline in vivo.
Toole BJ; Cohen PT
Cell Signal; 2007 May; 19(5):1044-55. PubMed ID: 17257813
[TBL] [Abstract][Full Text] [Related]
14. Decreased insulin action in skeletal muscle from patients with McArdle's disease.
Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356
[TBL] [Abstract][Full Text] [Related]
15. In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys.
Ortmeyer HK
J Nutr; 2001 Mar; 131(3):907S-912S. PubMed ID: 11238784
[TBL] [Abstract][Full Text] [Related]
16. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
Dokken BB; Henriksen EJ
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
[TBL] [Abstract][Full Text] [Related]
17. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats.
Cline GW; Johnson K; Regittnig W; Perret P; Tozzo E; Xiao L; Damico C; Shulman GI
Diabetes; 2002 Oct; 51(10):2903-10. PubMed ID: 12351425
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of vanadium in diabetic rats are independent of changes in PI-3 kinase activity in skeletal muscle.
Mohammad A; Bhanot S; McNeill JH
Mol Cell Biochem; 2001 Jul; 223(1-2):103-8. PubMed ID: 11681710
[TBL] [Abstract][Full Text] [Related]
19. Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.
Henriksen EJ; Teachey MK
Metabolism; 2007 Jul; 56(7):931-8. PubMed ID: 17570255
[TBL] [Abstract][Full Text] [Related]
20. The effect of modulating the glycogen-associated regulatory subunit of protein phosphatase-1 on insulin action in rat skeletal muscle cells.
Ragolia L; Begum N
Endocrinology; 1997 Jun; 138(6):2398-404. PubMed ID: 9165028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
